Corrigendum: pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/ cyclin-dependent kinase 2 dual inhibitors

HIGHLIGHTS

• who: Correction and colleagues from the Frontiers Media SA, SwitzerlandDepartment of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh have published the research: Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/ cyclin-dependent kinase 2 dual inhibitors, in the Journal: (JOURNAL)

SUMMARY

Pyrazolyl-s-triazine, indole, anticancer profile, EGFR/CDK-2, apoptosis A Corrigendum on Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors by Shawish I, Nafie MS, Barakat A . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.